COSCIENS BIOPHARMA INC (CSCI) Stock Overview
NASDAQ:CSCI - CA22112H1010 - Common Stock
CSCI Key Statistics, Chart & Performance
The current stock price of CSCI is 2.72 USD. In the past month the price decreased by -31.14%. In the past year, price decreased by -32%.
CSCI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.07 | 375.50B | ||
| AMGN | AMGEN INC | 13.01 | 152.70B | ||
| GILD | GILEAD SCIENCES INC | 14.86 | 142.76B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.38 | 101.56B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.56 | 60.77B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.25B | ||
| ARGX | ARGENX SE - ADR | 80.99 | 45.95B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.99 | 40.63B | ||
| INSM | INSMED INC | N/A | 30.67B | ||
| BNTX | BIONTECH SE-ADR | N/A | 27.03B | ||
| NTRA | NATERA INC | N/A | 23.06B | ||
| BIIB | BIOGEN INC | 8.79 | 20.62B |
Related stock screener links
About CSCI
Company Profile
COSCIENS Biopharma Inc. engages in the development and commercialization of diverse pharmaceutical and diagnostic products. The company is headquartered in Toronto, Ontario. The firm is developing and commercializing a diversified portfolio of products for the cosmeceutical, nutraceutical and pharmaceutical markets. The Company’s patented technologies include the Pressurized Gas eXpanded (PGX) technology, which is a technology that generates high-value yields of active ingredients from natural-based resources for use in novel cosmeceutical, nutraceutical and pharmaceutical products. The firm's two products, oat beta glucan and avenanthramides, are found in household-name cosmetic and personal care brands. These products are manufactured from the Company’s proprietary oat extraction manufacturing technology and are known for their well-documented health benefits. Its lead product, macimorelin (Macrilen; Ghryvelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD).
Company Info
COSCIENS BIOPHARMA INC
C/O Norton Rose Fulbright Canada Llp, 222 Bay Street, Suite 3000, Po Box 53
TORONTO ONTARIO CA
Employees: 21
Phone: 18439003201
COSCIENS BIOPHARMA INC / CSCI FAQ
What is the stock price of COSCIENS BIOPHARMA INC today?
The current stock price of CSCI is 2.72 USD. The price decreased by -11.69% in the last trading session.
What is the ticker symbol for COSCIENS BIOPHARMA INC stock?
The exchange symbol of COSCIENS BIOPHARMA INC is CSCI and it is listed on the Nasdaq exchange.
On which exchange is CSCI stock listed?
CSCI stock is listed on the Nasdaq exchange.
What is COSCIENS BIOPHARMA INC worth?
COSCIENS BIOPHARMA INC (CSCI) has a market capitalization of 8.65M USD. This makes CSCI a Nano Cap stock.
How many employees does COSCIENS BIOPHARMA INC have?
COSCIENS BIOPHARMA INC (CSCI) currently has 21 employees.
What are the support and resistance levels for COSCIENS BIOPHARMA INC (CSCI) stock?
COSCIENS BIOPHARMA INC (CSCI) has a support level at 2.65 and a resistance level at 3.26. Check the full technical report for a detailed analysis of CSCI support and resistance levels.
Should I buy COSCIENS BIOPHARMA INC (CSCI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CSCI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CSCI, evaluating the profitability, health, valuation and growth aspects
- COSCIENS BIOPHARMA INC (CSCI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- COSCIENS BIOPHARMA INC (CSCI) Sales and EPS estimates to see what analysts future expectations are.
- COSCIENS BIOPHARMA INC (CSCI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- COSCIENS BIOPHARMA INC (CSCI) Insider and Institutional Ownership to learn about the owners and their transactions.
- COSCIENS BIOPHARMA INC (CSCI) Stock Chart to make your own analysis
- COSCIENS BIOPHARMA INC (CSCI) Latest news and press-releases to stay up to date.
Does COSCIENS BIOPHARMA INC (CSCI) stock pay dividends?
CSCI does not pay a dividend.
When does COSCIENS BIOPHARMA INC (CSCI) report earnings?
COSCIENS BIOPHARMA INC (CSCI) will report earnings on 2025-11-10.
What is the Price/Earnings (PE) ratio of COSCIENS BIOPHARMA INC (CSCI)?
COSCIENS BIOPHARMA INC (CSCI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.8).
What is the Short Interest ratio of COSCIENS BIOPHARMA INC (CSCI) stock?
The outstanding short interest for COSCIENS BIOPHARMA INC (CSCI) is 0.32% of its float. Check the ownership tab for more information on the CSCI short interest.
CSCI Technical Analysis
CSCI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CSCI. CSCI has a bad profitability rating. Also its financial health evaluation is rather negative.
CSCI Financial Highlights
Over the last trailing twelve months CSCI reported a non-GAAP Earnings per Share(EPS) of -5.8. The EPS increased by 13.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -56.4% | ||
| ROE | -173.14% | ||
| Debt/Equity | 0.19 |